Brain Stimulation for Epilepsy
Trial Summary
What is the purpose of this trial?
A primary purpose of this study is to better understand what stimulation parameters work best for patients. For example, for Deep Brain Stimulation (DBS) of the Anterior Nucleus of the Thalamus (ANT), it is not clear what stimulation frequency leads is most effective. This study will help assess the effectiveness of low frequency or high frequency stimulation.
Will I have to stop taking my current medications?
The trial information does not specify whether you need to stop taking your current medications. It's best to discuss this with the trial coordinators or your doctor.
What data supports the effectiveness of the treatment Deep Brain Stimulation (DBS) for epilepsy?
Deep Brain Stimulation (DBS) has shown promising results in reducing seizures for people with epilepsy that doesn't respond to medication. Studies indicate that targeting specific brain areas, like the anterior nucleus of the thalamus, can help decrease seizure frequency and improve quality of life.12345
Is deep brain stimulation (DBS) safe for humans?
How does the treatment Deep Brain Stimulation (DBS) for epilepsy differ from other treatments?
Deep Brain Stimulation (DBS) is unique because it involves implanting a device that sends electrical impulses to specific brain areas to control seizures, especially for patients who don't respond to medication or surgery. Unlike other treatments, DBS is minimally invasive and reversible, offering a new option for those with drug-resistant epilepsy.1291011
Eligibility Criteria
This trial is for individuals with seizures or epilepsy. Participants should be candidates for Deep Brain Stimulation (DBS) and specifically targeting the Anterior Nucleus of the Thalamus (ANT). The study will exclude certain people, but those details are not provided here.Inclusion Criteria
Exclusion Criteria
Trial Timeline
Screening
Participants are screened for eligibility to participate in the trial
Treatment
Participants receive Deep Brain Stimulation (DBS) with varying frequency parameters to assess effectiveness
Follow-up
Participants are monitored for safety and effectiveness after treatment
Treatment Details
Interventions
- Stimulation Set A and B (Procedure)
Stimulation Set A and B is already approved in European Union, United States for the following indications:
- Parkinson's disease
- Essential tremor
- Dystonia
- Epilepsy
- Obsessive-compulsive disorder
- Parkinson's disease
- Essential tremor
- Dystonia
- Epilepsy
- Obsessive-compulsive disorder